Sarepta therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4)

Cambridge, mass.--(business wire)--sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, granted equity awards on november 29, 2024 (the “grant date”) that were previously approved by the compensation committee of its board of directors under sarepta's 2024 employment commencement incentive plan, as a material inducement to employment to 14 individuals hired by sarepta in november 2024. the equity awards were approved in accordance with nasdaq lis.
SRPT Ratings Summary
SRPT Quant Ranking